EPISODE · Sep 9, 2025 · 25 MIN
Ep. 18 - GLP1 Medications Heart Health and Environmental Impact
from The Scalpel's Edge · host Dr. Tim Sayed
On this episode of The Scalpel’s Edge we explore a fascinating new study showing how GLP1 medications like semaglutide and tirzepatide may not only improve heart failure outcomes but also reduce greenhouse gas emissions. As I break down this meta-analysis presented at the European Society of Cardiology Congress you will hear how these drugs can deliver benefits for individual patients while also contributing to global sustainability efforts. Small improvements at the patient level may add up to big impacts for population health and our environment. Join me as we dive into how these therapies are shaping the future of medicine and wellness.Contact Dr. Tim Sayed:Phone: (858) 247-2933Email: [email protected]: timsayedmd.comInstagram: @timsayedmdYouTube: @TimsayedmdFacebook: Tim Sayed MD
Embed this episode
What this episode covers
On this episode of The Scalpel’s Edge we explore a fascinating new study showing how GLP1 medications like semaglutide and tirzepatide may not only improve heart failure outcomes but also reduce greenhouse gas emissions. As I break down this meta-analysis presented at the European Society of Cardiology Congress you will hear how these drugs can deliver benefits for individual patients while also contributing to global sustainability efforts. Small improvements at the patient level may add up ...
NOW PLAYING
Ep. 18 - GLP1 Medications Heart Health and Environmental Impact
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.